Article

Gene therapy breakthrough seen in Leber's congenital amaurosis

Philadelphia-Much progress has been made in the development of gene therapies for retinal dystrophies during the last decade. Albert Maguire, MD

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
Related Content
HanAll Biopharma receives Orphan Drug Designation in Japan for Batoclimab for thyroid eye disease
March 18th 2025

HanAll Biopharma receives Orphan Drug Designation in Japan for Batoclimab for thyroid eye disease

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Harrow launches partnership with mail-order pharmacy, PhilRx to expand access to VEVYE
March 17th 2025

Harrow launches partnership with mail-order pharmacy, PhilRx to expand access to VEVYE

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Stealth BioTherapeutics reaches 50 percent enrollment target in phase 3 ReNEW study
March 17th 2025

Stealth BioTherapeutics reaches 50 percent enrollment target in phase 3 ReNEW study

Preclinical study of KIO-104 in a proliferative vitreoretinopathy model accepted for poster presentation at ARVO 2025
March 17th 2025

Preclinical study of KIO-104 in a proliferative vitreoretinopathy model accepted for poster presentation at ARVO 2025

© 2025 MJH Life Sciences

All rights reserved.